Pieris Pharmaceuticals Inc (NASDAQ: PIRS): Forecast Weak In 2024, Up -82.53%

The trading price of Pieris Pharmaceuticals Inc (NASDAQ:PIRS) closed lower on Friday, April 19, closing at $0.14, -6.60% lower than its previous close.

In examining the 52-week price action we see that the stock hit a 52-week high of $1.01 and a 52-week low of $0.14. Over the past month, the stock has lost -30.95% in value.

Pieris Pharmaceuticals Inc, whose market valuation is $14.35 million at the time of this writing. Investors’ optimism about the company’s current quarter earnings report is understandable.

A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Pieris Pharmaceuticals Inc No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest PIRS has a Hold on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.

A quick review shows that PIRS’s price is currently -18.44% off the SMA20 and -16.71% off the SMA50. The RSI metric on the 14-day chart is currently showing 31.03, and weekly volatility stands at 9.77%. When measured over the past 30 days, the indicator reaches 8.12%. Pieris Pharmaceuticals Inc (NASDAQ:PIRS)’s beta value is currently sitting at 0.54, while the Average True Range indicator is currently displaying 0.02.

To see how Pieris Pharmaceuticals Inc stock has been performing in comparison to its peers in the industry, here are the numbers: PIRS stock’s performance was -6.60% in the latest trading, and -82.53% in the past year.

An evaluation of the daily trading volume of Pieris Pharmaceuticals Inc (NASDAQ:PIRS) indicates that the 3-month average is 610.20K.

Currently, records show that 98.94 million of the company’s shares remain outstanding. The insiders hold 7.45% of outstanding shares, whereas institutions hold 38.94%. However, since the stock’s price has seen -20.33% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.

Most Popular